drugset / Trial / NCT03973840
Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
Phase 1
Completed
13 enrolled
Clarus Therapeutics, Inc.
Celerion; Syneos Health; ARUP Laboratories · collab
NaSingle-groupOpen-labelDiagnostic
Summary
To describe the rate of post-collection TU to testosterone conversion, as manifested by increases in testosterone concentration, in Plain tubes held at room temperature and sodium fluoride (NaF)-ethylenediaminetetraacetic acid (EDTA) tubes held at room temperature or on ice prior to centrifugation
Timeline
- Start
- 2018-07-15
- Primary completion
- 2018-07-31
- Completion
- 2018-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Testosterone Undecanoate | Small molecule | — | Oral |